Guangdong Tainkang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 16th meeting of the 5th Board of Directors on April 24, 2026, and the 2025 Annual General Meeting on May 20, 2026, where it approved the proposal to change the registered capital and amend the Articles of Association. Given that the distribution of equity for the year 2025 was completed on June 1, 2026, the total share capital has changed from 425,497,500 shares to 510,597,000 shares, and the registered capital has changed from RMB 425,497,500 to RMB 510,597,000. Details can be found in the announcements dis
301263SZSE
Announcement on Completion of Industrial and Commercial Change Registration
✨ AI Summary
Guangdong Tainkang Pharmaceutical Co., Ltd. completed its industrial and commercial change registration following the approval of changes to its registered capital and articles of association. The total share capital increased from 425,497,500 shares to 510,597,000 shares, and the registered capital changed from RMB 425,497,500 to RMB 510,597,000. The company has obtained a new business license from the Shantou Market Supervision Administration.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.